OPB-101: An optimized mesothelin-specific CAR T cell product expressing CD8-targeted IL-2/15 and engineered to resist T cell exhaustion

Join the team

Join the Outpace team as we unleash the full potential of cells to cure.

Work together

We collaborate with leading biopharma and academics who share our vision of creating a future where all cell therapies are effective and safe.